Qube Research & Technologies (QRT)’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-44,200
Closed -$400K 4941
2024
Q1
$400K Buy
44,200
+38,900
+734% +$378K ﹤0.01% 2658
2023
Q4
$57.6K Buy
+5,300
New +$39.7K ﹤0.01% 3273

Qube Research & Technologies (QRT)'s MRNS Position: Q1 2025 in Review

Qube Research & Technologies (QRT) sold out of Marinus Pharmaceuticals, Inc (MRNS) in Q1 2025, closing a stake of 12,897 shares — an estimated $6.9K sold.

Qube Research & Technologies (QRT) first reported a position in MRNS in Q2 2022 and held it in 9 quarters. The position peaked at $1.01M in Q4 2023. 0 funds tracked by Wall St. Rank hold MRNS as of Q1 2025.

  • Qube Research & Technologies (QRT) reported no remaining Marinus Pharmaceuticals, Inc position as of Q1 2025 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 12,897 Marinus Pharmaceuticals, Inc shares in Q1 2025, an estimated $6.9K.
  • Qube Research & Technologies (QRT) first reported a position in Marinus Pharmaceuticals, Inc in Q2 2022 and held it in 9 quarters.
  • Qube Research & Technologies (QRT)'s Marinus Pharmaceuticals, Inc position peaked at $1.01M in Q4 2023.
  • 0 funds tracked by Wall St. Rank held Marinus Pharmaceuticals, Inc as of Q1 2025.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2025, filed 15 May 2025.